Hermes Vector

Politics

White House Withdraws Heidi Overton's FDA Commissioner Nomination

The White House has dropped Dr. Heidi Overton's nomination to lead the Food and Drug Administration hours before a scheduled Senate committee vote, leaving the agency without a permanent leader.

By Hermes Vector

Also in: Español · Português · Français · 中文

Checked against 6 sourcescbsnews.comNBC NewsThe Guardianwng.orgmddionline.comCNN
Illustration for: White House Withdraws Heidi Overton's FDA Commissioner Nomination

In brief

  • The White House withdrew Dr. Heidi Overton's nomination to lead the FDA hours before a Senate committee vote.
  • Sen. Bill Cassidy said the White House abandoned a viable confirmation path and that Overton would have had the votes to pass.
  • The FDA has been without a permanent commissioner since Dr. Marty Makary left the role in May.
  • The withdrawal leaves the FDA without a permanent leader before Democrats take control of the Senate in January.

White House Withdraws Heidi Overton's FDA Commissioner Nomination

The White House has withdrawn Dr. Heidi Overton's nomination to serve as commissioner of the Food and Drug Administration, according to a senior administration official and people familiar with the decision. The withdrawal came late Tuesday, hours before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on advancing her nomination.

Senate Reaction

Sen. Bill Cassidy of Louisiana, the outgoing chair of the Senate HELP Committee, said the White House abandoned a viable confirmation path. Cassidy wrote in a statement that "pro-life Senators sought final assurances from the Administration regarding the Administration's commitment to life issues," but the Trump administration withdrew Overton instead.

"I believe she would have had the votes to pass out of committee and pass the full Senate," Cassidy said. "My conversations with her convinced me she would follow the science and push back against decisions that put Americans' health at risk."

Cassidy also said that with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.

Background on the Nomination

President Trump nominated Overton, a physician and White House domestic policy staffer, to the FDA role in August. She had served as chief policy officer at the conservative think tank America First Policy Institute before joining the White House.

Overton faced questions from senators about her experience, her position on the administration's proposal to separate the combined measles-mumps-rubella vaccine into three individual doses, and her stance on the abortion drug mifepristone. The FDA is set to finish its safety review of mifepristone in March.

To clear the 21-member Senate health committee, Overton needed support from all 12 Republican members, since all 11 Democrats were expected to oppose her.

FDA Leadership

The FDA has been without a permanent commissioner since Dr. Marty Makary left the role in May. Kyle Diamantas has been serving as the acting FDA commissioner since then. The agency regulates products that account for about 20% of U.S. consumer spending.

Why it matters

The withdrawal leaves the FDA without a permanent leader as Republicans' window to confirm a commissioner before ceding Senate control to Democrats in January continues to close. Any Senate-confirmed FDA commissioner would need to be confirmed during a narrow window before Democrats take control of the chamber in January.


Sources

This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.

Questions readers ask

Who withdrew Heidi Overton's nomination to be FDA commissioner?
The White House withdrew Dr. Heidi Overton's nomination to serve as commissioner of the Food and Drug Administration.
When was the nomination withdrawn?
The withdrawal came late Tuesday, hours before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on advancing her nomination.
Why did Sen. Bill Cassidy say the nomination was withdrawn?
Cassidy said pro-life Senators sought final assurances from the Administration regarding the Administration's commitment to life issues, but the Trump administration withdrew Overton instead.
Who is currently serving as acting FDA commissioner?
Kyle Diamantas has been serving as the acting FDA commissioner since May.
Why does the withdrawal of the nomination matter?
The withdrawal leaves the FDA without a permanent leader as Republicans' window to confirm a commissioner before ceding Senate control to Democrats in January continues to close.

The day's checked news, by email

One short email a day with the top stories. Free, and you can unsubscribe in one click.

Or follow for the latest news:

How do you feel about this story?

Comments 0

No comments yet. Start the discussion.